Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Grenabo Bergdahl
Observed names:
A. Grenabo,
A. Grenabo Bergdahl,
A.G.B. Grenabo Bergdahl,
A.L.A. Grenabo,
Anna Grenabo,
Bergdahl A. Grenabo
show all 6
Institutions:
Sahlgrenska University Hospital,
Region Västra Götaland,
University of Gothenburg
Observed institutions:
Sahlgrenska University Hospital,
Erasmus MC,
Region Västra Götaland,
Skaraborg Hospital,
University of Gothenburg
ORCID:
0000-0003-3266-7611
Observed ORCID:
0000-0003-3266-7611
OpenAlex ID:
A5062849817
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality
2017
·
Jonas Hugosson
, Rebecka Arnsrud Godtman
, et al.
·
Scandinavian Journal of Urology
·
131
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial
2015
·
Anna Grenabo Bergdahl
, Ulrica Wilderäng
, et al.
·
European Urology
·
88
Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam
2007
·
M. J. Roobol
, A. Grenabo
, et al.
·
JNCI Journal of the National Cancer Institute
·
80
Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial
2013
·
Anna Grenabo Bergdahl
, Erik Holmberg
, et al.
·
European Urology
·
46
Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre
2022
·
Anna Grenabo Bergdahl
, Marianne Månsson
, et al.
·
BJUI Compass
·
35
PDF
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
2021
·
Axel Gerdtsson
, Anna Thor
, et al.
·
European Urology Oncology
·
29
Risk of dying from prostate cancer in men randomized to screening: Differences between attendees and nonattendees
2009
·
Anna Grenabo Bergdahl
, Gunnar Aus
, et al.
·
Cancer
·
23
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
2024
·
Anna Thor
, Helene F.S. Negaard
, et al.
·
European Urology Open Science
·
21
SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma
2023
·
Oi Kuan Choong
, Rasmus Jakobsson
, et al.
·
PLoS ONE
·
20
PDF
miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
2024
·
Anna Thor
, Mette Pernille Myklebust
, et al.
·
The Journal of Urology
·
16
Long-term efficacy of selective arterial embolisation of renal angiomyolipoma
2023
·
Jesper Swärd
, Karl Bohlin
, et al.
·
Scandinavian Journal of Urology
·
15
PDF
Predictors for complication in renal cancer surgery: a national register study
2023
·
John Åkerlund
, Pernilla Sundqvist
, et al.
·
Scandinavian Journal of Urology
·
11
PDF
760 Role of magnetic resonance imaging in prostate cancer screening; results from a pilot study within the Gothenburg randomized screening trial
2015
·
Bergdahl A. Grenabo
, S. Carlsson
, et al.
·
European Urology Supplements
·
8
Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study
2023
·
Rasmus G. Jakobsson
, Salmir Nasic
, et al.
·
The Journal of Urology
·
7
Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne.
2023
·
Torgrim Tandstad
, Anders Kjellman
, et al.
·
Journal of Clinical Oncology
·
7
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients
2023
·
Axel Gerdtsson
, Gustav Torisson
, et al.
·
British Journal of Urology
·
5
PDF
Corrigendum re: “Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial” [Eur Urol 2016;70:566–73]
2016
·
Anna Grenabo Bergdahl
, Ulrica Wilderäng
, et al.
·
European Urology
·
5
Renal angiomyolipoma-investigating radiological signs indicative of risk for bleeding
2025
·
Jesper Swärd
, Karl Bohlin
, et al.
·
Insights into Imaging
·
3
PDF
End-stage renal disease after renal cancer surgery: risk factors and overall survival
2024
·
John Åkerlund
, Börje Ljungberg
, et al.
·
Scandinavian Journal of Urology
·
3
PDF
MP33-04 THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3cm
2023
·
Anna Thor
, Axel Gerdtsson
, et al.
·
The Journal of Urology
·
3
PDF
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours
2024
·
Axel Gerdtsson
, Helene F. S. Negaard
, et al.
·
British Journal of Urology
·
2
PDF
87 18-year follow up of the Gothenburg randomized population-based prostate cancer screening trial
2016
·
R. Arnsrud Godtman
, S. Carlsson
, et al.
·
European Urology Supplements
·
2
2 Incidence and mortality of prostate cancer after termination of PSA based screening
2013
·
A.L.A. Grenabo
, E. Holmberg
, et al.
·
European Urology Supplements
·
2
Ip13-12 Primary Retroperitoneal Lymph Node Dissection (rplnd) for Clinical Stage Iia/iib Seminoma – Updated Population-based Results From Swedish and Norwegian Testicular Cancer Group (swenoteca)
2026
·
Anna Thor
, Bjarte Almås
, et al.
·
The Journal of Urology
PDF
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA
2026
·
Anna Thor
, Anna Grenabo Bergdahl
, et al.
·
Scandinavian Journal of Urology
PDF
Show more works
View as search
Works count:
42
Citation count:
562
H-index:
11
I10-index:
12
Year
Topic
Type